BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information Letter on Erwinase® 10,000 IU/vial (crisantaspase): Instructions for use and shortage

2016.06.02

Active substance: crisantaspase

The company Jazz Pharmaceuticals Germany GmbH is circulating information on use and handling instructions (visual inspection and filtering) of the Erwinase batch 174G imported from the United Kingdom.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 139KB, File does not meet accessibility standards

Use of cookies

Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)

OK